Rojas-Salazar, Y.;                     Gómez-Montañez, E.;                     Rojas-Salazar, J.;                     de Anda-Jáuregui, G.;                     Hernández-Lemus, E.    
        Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors. Int. J. Mol. Sci. 2024, 25, 12840.
    https://doi.org/10.3390/ijms252312840
    AMA Style
    
                                Rojas-Salazar Y,                                 Gómez-Montañez E,                                 Rojas-Salazar J,                                 de Anda-Jáuregui G,                                 Hernández-Lemus E.        
                Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors. International Journal of Molecular Sciences. 2024; 25(23):12840.
        https://doi.org/10.3390/ijms252312840
    
    Chicago/Turabian Style
    
                                Rojas-Salazar, Yareli,                                 Emiliano Gómez-Montañez,                                 Jorge Rojas-Salazar,                                 Guillermo de Anda-Jáuregui,                                 and Enrique Hernández-Lemus.        
                2024. "Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors" International Journal of Molecular Sciences 25, no. 23: 12840.
        https://doi.org/10.3390/ijms252312840
    
    APA Style
    
                                Rojas-Salazar, Y.,                                 Gómez-Montañez, E.,                                 Rojas-Salazar, J.,                                 de Anda-Jáuregui, G.,                                 & Hernández-Lemus, E.        
        
        (2024). Potential Drug Synergy Through the ERBB2 Pathway in HER2+ Breast Tumors. International Journal of Molecular Sciences, 25(23), 12840.
        https://doi.org/10.3390/ijms252312840